Tyrosine kinase 3D structures
From Proteopedia
(Difference between revisions)
| Line 106: | Line 106: | ||
**[[2kk1]] – hTK C terminal – NMR<BR /> | **[[2kk1]] – hTK C terminal – NMR<BR /> | ||
| - | |||
| - | *'''Anaplastic lymphoma kinase (Alk)''' or Alk tyrosine kinae receptor; Domains – Gly-rich 678-986; TG+EGF=like 648-1030; kinase 1093-1411 | ||
| - | |||
| - | **[[4tt7]], [[6cdt]] - hTK kinase domain<br /> | ||
| - | **[[2yhv]], [[2yjr]], [[2yjs]], [[3l9p]], [[3lcs]], [[3lct]], [[4anl]], [[4fnw]], [[4fnx]] - hTK kinase domain (mutant)<br /> | ||
| - | **[[7lrz]], [[7mzw]], [[7mzy]] - hTK Gly-rich domain<br /> | ||
| - | **[[7nx4]] - hTK TG+EGF-like domain<br /> | ||
| - | **[[7nx3]] - hTK TG+EGF-like domain + antibody<br /> | ||
| - | **[[2xb7]], [[2xba]], [[3aox]], [[4ccb]], [[4ccu]], [[4cli]], [[4cmo]], [[4cmt]], [[4cmu]], [[4cnh]], [[4ctb]], [[4ctc]], [[5imx]], [[5kz0]], [[6edl]], [[6ebw]], [[6e0r]], [[6mx8]], [[7btt]], [[7jy4]], [[7jyr]], [[7jys]], [[7jyt]], [[8arj]] - hTK kinase domain + inhibitor<br /> | ||
| - | **[[4dce]], [[4fob]], [[4foc]], [[4fod]], [[4fny]], [[4fnz]], [[4joa]], [[4mkc]], [[4z55]], [[5iug]], [[5iuh]], [[5iui]], [[4cd0]], [[4clj]] - hTK kinase domain (mutant) + inhibitor<br /> | ||
| - | **[[2xp2]], [[5j7h]], [[5fto]], [[5ftq]], [[7r7k]], [[7r7r]] - hTK kinase domain + cancer drug<br /> | ||
| - | **[[2yfx]], [[4anq]], [[4ans]], [[5aaa]], [[5aab]], [[5aac]], [[5a9u]], [[5aa8]], [[5aa9]] - hTK kinase domain (mutant) + cancer drug<br /> | ||
| - | **[[7n00]], [[7nwz]]] - hTK kinase domain (mutant) + AUG-alpha<br /> | ||
| - | **[[7ls0]] - hTK kinase domain/AUG-alpha<br /> | ||
*'''Csk tyrosine kinase''' | *'''Csk tyrosine kinase''' | ||
Revision as of 10:01, 8 February 2024
3D structures of tyrosine kinase
Updated on 08-February-2024 - For a general description of the protein see Tyrosine kinase
